NYU will hold its first annual Dual-Energy CT Symposium Oct. 9-10 in New York City. The program is designed for radiologists who have or are considering acquiring a dual-energy scanner, research scientists who are looking to understand current uses of dual-energy CT to stimulate development of translational research projects, and technologists who need a basis in dual-energy terminology and concepts.
NYU will hold its first annual Dual-Energy CT Symposium Oct. 9-10 in New York City. The program is designed for radiologists who have or are considering acquiring a dual-energy scanner, research scientists who are looking to understand current uses of dual-energy CT to stimulate development of translational research projects, and technologists who need a basis in dual-energy terminology and concepts.
Dual-energy CT (DECT) acquisition provides the radiologist with an expanded set of diagnostic capabilities and alters CT imaging in significant ways. Those who have worked with the technology believe it offers significant patient benefit for improved lesion detection, chemical analysis of normal and pathologic tissue, and iodine mapping. Perhaps most significantly, DECT may allow significant patient dose reduction by eliminating noncontrast scanning. Exciting research is currently under way to use the technology in novel ways to analyze treatment responses.
Directed by Dr. Alec J. Megibow, this one-and-a-half-day symposium will bring together clinical physics experts who are currently using both dual- and single-source technology. Attendees will benefit from learning how different approaches to DECT can be used to benefit patient care in all areas of the body. Emphasis will be placed on workflow, integration of DECT software into clinical image evaluation, and highlighting established indications and where research is heading.
To see the full program and register online, click here.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.